(Q69110897)
Statements
Correlations between the cardiovascular effects of pimobendan and plasma concentrations of the parent compound and of its major active metabolite, UD-CG 212 CL, in patients with congestive heart failure (English)
Hagemeijer F
Roth W
1 January 1989
14 Suppl 2